FDA pharmacologic class
beta Lactamase Inhibitor
0 medicines are in FDA's class of beta lactamase inhibitors: ; 8 combination products also contain one. 3 of the 8 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is amox-clav 600-42.9 mg/5 ml sus at $0.0693 per mL (NADAC).
Which medicines are beta lactamase inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Amoxicillin and clavulanate | Augmentin | 31 labelers | $0.0693 per mL 600-42.9 mg/5 mL sus | No | No current entry | 5 |
| Piperacillin and tazobactam | Zosyn | 15 labelers | $3.49 per vial 3.375 g vial | No | A presentation being discontinued | 17 |
| Ampicillin and sulbactam | Unasyn | 12 labelers | n/a | No | No current entry | 17 |
| Avibactam and aztreonam | Emblaveo | none listed | n/a | No | No current entry | 0 |
| Avibactam and ceftazidime | Avycaz | none listed | n/a | No | No current entry | 0 |
| Ceftolozane and tazobactam | Zerbaxa | none listed | n/a | No | No current entry | 1 |
| Cilastatin and imipenem and relebactam | Recarbrio | none listed | n/a | No | A presentation being discontinued | 0 |
| Meropenem and vaborbactam | Vabomere | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price